Sorbact® is a registered trademark owned by
Sorbact
A recently published article in JWC showed that Sorbact® dressings have high antibacterial activity against the WHO prioritized bacteria. Read the article here.
The International Wound Infection Institute (IWII) has launched the third edition of their Wound Infection in Clinical Practice guidance. This important consensus document provides practical information based on the latest understanding of the science and clinical applications regarding wound infection.
EWMA organization has developed practically oriented documents and recommendations for people treating wounds as an effect of the current war in Ukraine (both HCPs and non-HCPs) throughout the last month. Please join us in sharing these guidelines throughout the medical community.
A narrative review of 169 published articles on bacteria-binding dressings concluded: “Wound dressings that use physical methods (bacterial-binding) of infection management are an ideal solution to antimicrobial resistance and should be aligned with antimicrobial stewardship”.
Hygiene and health company Essity has signed an agreement today to acquire the remaining 25% of the shares in the Swedish medical solutions company ABIGO Medical AB.
Sorbact® is live on LinkedIn, follow us for all the latest updates. Help us spread the word of Sorbact® wound dressings around the world through LinkedIn, like, share and react on our posts.
In the current circumstances with the spread of Covid-19 around the world, which necessitate the implementation of various measures and initiatives to protect our fellow humans and companies around the globe, the team at ABIGO Medical Group would like to reassure you that we are doing everything we can to minimize the impact.
Hygiene and health company Essity has signed an agreement to acquire 75% of the Swedish medical solutions company ABIGO Medical AB.
